Impact Factor
1.78
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.43
43 total citations
h5-index
6
h5 depth signal
Cited share
29.8%
31 of 104
Total citations
43
Citation footprint
Metric signal
0.46
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Spain
245
Turkey
56
China
32
Italy
28
United States
13
Citing Fields of Research
Oncology
210
Endocrinology & Metabolism
75
Auto-Inflammatory Disorders
75
Musculoskeletal & Nerve Cancer
70
Prostate Cancer
63
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,263
Articles tracked across the journal lifetime
Indexed publication set
104
31 cited publications
Last 12 months
75
7.5 publications/month
Open access share
2.7%
2 OA publications in the last year
Leading citing country
Spain
245 citing publications
Leading citing field
Oncology
210 citing publications
Latest tracked publication
31 August 2026
10 recent records available
Coverage & Indexing History
v37n1, Jan.-Feb. 2018-
v37n1, Jan.-Feb. 2018-
Research Focus & Classification
Indexed Subjects
Prostate Cancer
Oncology
Endocrinology & Metabolism
Lung Cancer
Breast Cancer
Lymphomas
Issuing & Sponsoring Bodies
Contributor
Sociedad Española de Medicina Nuclear e Imagen Molecular
Broad Categories
Nuclear Medicine
Prostate Cancer
Lung Cancer
Endocrinology & Metabolism
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Digestive Disorders
Osteopathies
MeSH Descriptors
Diagnostic Imaging
Nuclear Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.remnie.2026.500336
Open DOI
Practical consensus document on the use of [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
02
DOI 10.1016/j.remnie.2026.500355
Open DOI
Utility of total gastrointestinal transit scintigraphy in the evaluation of patients with VEDOSS and systemic sclerosis
03
04
DOI 10.1016/j.remnie.2026.500345
Open DOI
Sacral Neurolymphomatosis: Resolving a Clinical Enigma with 18F-FDG PET/MRI
05
DOI 10.1016/j.remnie.2026.500344
Open DOI
18F-FDG PET/CT metabolic parameters-derived prediction model for microsatellite instability in colorectal cancer
06
DOI 10.1016/j.remnie.2026.500335
Open DOI
Duration of levothyroxine discontinuation and pre-radioiodine TSH levels in thyroid cancer
07
DOI 10.1016/j.remnie.2026.500334
Open DOI
Proposed model to facilitate the surgical localization of the sentinel lymph node in gynecological tumors
08
09
DOI 10.1016/j.remnie.2026.500343
Open DOI
[18F]FDG PET/CT showing intense uptake in a scalp mass as the initial presentation of grade 3 neuroendocrine neoplasm
10
Bibliographical & Catalog Notes
Some providers have title: Revista española de medicina nuclear e imagen molecular (English edition).
Also called: Spanish journal of nuclear medicine and molecular imaging.
Also called: Spanish review of nuclear medicine and molecular imaging.
Running title, Mar./Apr. 2012-: Rev Esp Med Nucl Imagen Mol.
Running title, Jan./Feb. 2012: Rev Esp Med Nucl.
Issued also in Spanish: Revista española de medicina nuclear e imagen molecular 2253-654X (DLC) 2012243668 (OCoLC)813406186 (DNLM)101585329.